Concepedia
Statistics
Publications
42
Citations
2.5K
H-Index
30
Active since
2005
Affiliations
University of Cambridge(Current)
Cambridge University Hospitals NHS Foundation Trust
Addenbrooke's Hospital
GlaxoSmithKline (United States)
University of Edinburgh
Joseph Cheriyan is an author at University of Cambridge specializing in medicine, vascular biology, and pharmacology.
Top concepts
MedicineVascular BiologyPharmacologyCardiovascular DiseaseImmunologyPhysiologyInflammationHealthHypertensionCell Signaling
Publications per year
2005–2023
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
Kaisa Mäki-Petäjä, Maysoon Elkhawad, Joseph Cheriyan et al. · Circulation · 2012 · 212 citations
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Aili L. Lazaar, Lucy Yang, Rebecca Boardley et al. · British Journal of Clinical Pharmacology · 2015 · 171 citations · Full text
Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist
Aimée Brame, Janet J. Maguire, Peiran Yang et al. · Hypertension · 2015 · 151 citations · Full text
Heart Failure, Peptide Science, Pharmacotherapy +22
Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis
Maysoon Elkhawad, James H.F. Rudd, Lea Sarov‐Blat et al. · JACC. Cardiovascular imaging · 2012 · 149 citations
Inflammation, Thrombosis, Vascular Disease +10
Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects
Navin Goyal, Peter J. Skrdla, Rosemary Schroyer et al. · American Journal of Cardiovascular Drugs · 2019 · 139 citations · Full text
1–5 of 42